{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:00:49Z","timestamp":1790168449493,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00521"],"award-info":[{"award-number":["PI20\/00521"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04444-6","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:45:53Z","timestamp":1782996353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic landscape of peripheral T cells following CAR-T cell therapy in diffuse large B cell lymphoma"],"prefix":"10.1007","volume":"75","author":[{"given":"Ismael","family":"de la Iglesia-San Sebasti\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fern\u00e1ndez de C\u00f3rdoba-O\u00f1ate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Bastos-Oreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Fern\u00e1ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"L\u00f3pez-Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Bail\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"G\u00f3mez-Centuri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Anguita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Garc\u00eda-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Bu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Mart\u00ednez-Laperche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"3","key":"4444_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/S12185-024-03780-6\/FIGURES\/1","volume":"121","author":"Y Naoi","year":"2025","unstructured":"Naoi Y, Ennishi D (2025) Understanding the intrinsic biology of diffuse large B-cell lymphoma: recent advances and future prospects. Int J Hematol 121(3):321\u2013325. https:\/\/doi.org\/10.1007\/S12185-024-03780-6\/FIGURES\/1","journal-title":"Int J Hematol"},{"issue":"9","key":"4444_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G (2021) Diffuse large B-cell lymphoma. N Engl J Med 384(9):842\u2013858. https:\/\/doi.org\/10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"issue":"4","key":"4444_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMOA2115304","volume":"386","author":"H Tilly","year":"2022","unstructured":"Tilly H et al (2022) Polatuzumab Vedotin in previously untreated diffuse large B-cell lymphoma. N Engl J Med 386(4):351\u2013363. https:\/\/doi.org\/10.1056\/NEJMOA2115304","journal-title":"N Engl J Med"},{"issue":"7","key":"4444_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJMC2030164","volume":"384","author":"EA Chong","year":"2021","unstructured":"Chong EA, Ruella M, Schuster SJ (2021) Five-year outcomes for refractory B-cell lymphomas with CAR T-cell therapy. N Engl J Med 384(7):673\u2013674. https:\/\/doi.org\/10.1056\/NEJMC2030164","journal-title":"N Engl J Med"},{"key":"4444_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.semcancer.2019.11.004","volume":"65","author":"S Lesch","year":"2020","unstructured":"Lesch S et al (2020) Determinants of response and resistance to CAR T cell therapy. Semin Cancer Biol 65:80\u201390. https:\/\/doi.org\/10.1016\/j.semcancer.2019.11.004","journal-title":"Semin Cancer Biol"},{"key":"4444_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06830-3","author":"L Shao","year":"2022","unstructured":"Shao L et al (2022) Identification of genomic signatures in bone marrow associated with clinical response of CD19 CAR T-cell therapy. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-06830-3","journal-title":"Sci Rep"},{"issue":"4","key":"4444_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1158\/2643-3230.BCD-20-0227","volume":"2","author":"NWCJ van de Donk","year":"2021","unstructured":"van de Donk NWCJ, Themeli M, Usmani SZ (2021) Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma. Blood Cancer Discov 2(4):302. https:\/\/doi.org\/10.1158\/2643-3230.BCD-20-0227","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"4444_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-023-00958-9","volume":"13","author":"J Zhao","year":"2023","unstructured":"Zhao J et al (2023) The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma. Blood Cancer J 13(1):1\u201311. https:\/\/doi.org\/10.1038\/s41408-023-00958-9","journal-title":"Blood Cancer J"},{"issue":"1","key":"4444_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-024-01193-6","volume":"14","author":"Z Tao","year":"2024","unstructured":"Tao Z et al (2024) Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies. Blood Cancer J 14(1):1\u201310. https:\/\/doi.org\/10.1038\/s41408-024-01193-6","journal-title":"Blood Cancer J"},{"issue":"7","key":"4444_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jcyt.2024.03.003","volume":"26","author":"HW Song","year":"2024","unstructured":"Song HW et al (2024) CAR-T cell expansion platforms yield distinct T cell differentiation states. Cytotherapy 26(7):757\u2013768. https:\/\/doi.org\/10.1016\/j.jcyt.2024.03.003","journal-title":"Cytotherapy"},{"issue":"8010","key":"4444_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-024-07300-8","volume":"629","author":"AE Doan","year":"2024","unstructured":"Doan AE et al (2024) FOXO1 is a master regulator of memory programming in CAR T cells. Nature 629(8010):211\u2013218. https:\/\/doi.org\/10.1038\/s41586-024-07300-8","journal-title":"Nature"},{"issue":"6","key":"4444_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/NM.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long AH et al (2015) 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med 21(6):581\u2013590. https:\/\/doi.org\/10.1038\/NM.3838","journal-title":"Nat Med"},{"issue":"2","key":"4444_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","volume":"44","author":"OU Kawalekar","year":"2016","unstructured":"Kawalekar OU et al (2016) Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. Immunity 44(2):380\u2013390. https:\/\/doi.org\/10.1016\/j.immuni.2016.01.021","journal-title":"Immunity"},{"issue":"10","key":"4444_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00262-017-2026-7","volume":"66","author":"S Battella","year":"2017","unstructured":"Battella S et al (2017) Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy. Cancer Immunol Immunother 66(10):1295\u20131306. https:\/\/doi.org\/10.1007\/s00262-017-2026-7","journal-title":"Cancer Immunol Immunother"},{"key":"4444_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/JITC-2024-010709","author":"C Junkuhn","year":"2025","unstructured":"Junkuhn C et al (2025) Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin\u2019s lymphoma. J Immunother Cancer. https:\/\/doi.org\/10.1136\/JITC-2024-010709","journal-title":"J Immunother Cancer"},{"issue":"12","key":"4444_CR16","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/J.YMTHE.2020.07.023","volume":"28","author":"AC Boroughs","year":"2020","unstructured":"Boroughs AC et al (2020) A distinct transcriptional program in human CAR T cells bearing the 4-1BB signaling domain revealed by scRNA-Seq. Mol Ther 28(12):2577. https:\/\/doi.org\/10.1016\/J.YMTHE.2020.07.023","journal-title":"Mol Ther"},{"issue":"21","key":"4444_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS14215442","volume":"14","author":"J Rial Saborido","year":"2022","unstructured":"Rial Saborido J, V\u00f6lkl S, Aigner M, Mackensen A, Mougiakakos D (2022) Role of CAR T Cell metabolism for therapeutic efficacy. Cancers 14(21):5442. https:\/\/doi.org\/10.3390\/CANCERS14215442","journal-title":"Cancers"},{"issue":"1","key":"4444_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00823-w","volume":"6","author":"K Shah","year":"2021","unstructured":"Shah K, Al-Haidari A, Sun J, Kazi JU (2021) T cell receptor (TCR) signaling in health and disease. Signal Transduct Target Ther 6(1):1\u201326. https:\/\/doi.org\/10.1038\/s41392-021-00823-w","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"4444_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/J.MOLMED.2017.03.002","volume":"23","author":"ZNL Chang","year":"2017","unstructured":"Chang ZNL, Chen YY (2017) CARs: synthetic immunoreceptors for cancer therapy and beyond. Trends Mol Med 23(5):430. https:\/\/doi.org\/10.1016\/J.MOLMED.2017.03.002","journal-title":"Trends Mol Med"},{"issue":"1","key":"4444_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/S40425-018-0385-Z","volume":"6","author":"BO Tschumi","year":"2018","unstructured":"Tschumi BO et al (2018) CART cells are prone to Fas- and DR5-mediated cell death. J Immunother Cancer 6(1):71. https:\/\/doi.org\/10.1186\/S40425-018-0385-Z","journal-title":"J Immunother Cancer"},{"issue":"8034","key":"4444_CR21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41586-024-07762-w","volume":"634","author":"Z Bai","year":"2024","unstructured":"Bai Z et al (2024) Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission. Nature 634(8034):702\u2013711. https:\/\/doi.org\/10.1038\/s41586-024-07762-w","journal-title":"Nature"},{"issue":"27","key":"4444_CR22","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133067. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"4444_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1378944","volume":"15","author":"L Levstek","year":"2024","unstructured":"Levstek L, Jan\u017ei\u010d L, Ihan A, Kopitar AN (2024) Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives. Front Immunol 15:1378944. https:\/\/doi.org\/10.3389\/fimmu.2024.1378944","journal-title":"Front Immunol"},{"issue":"1","key":"4444_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/bjh.19916","volume":"206","author":"I de la Iglesia-San Sebasti\u00e1n","year":"2025","unstructured":"de la Iglesia-San Sebasti\u00e1n I et al (2025) Chimeric antigen receptor copies in cell-free DNA predict relapse in aggressive B-cell lymphoma patients treated with CAR T-cell therapy. Br J Haematol 206(1):195\u2013203. https:\/\/doi.org\/10.1111\/bjh.19916","journal-title":"Br J Haematol"},{"key":"4444_CR25","doi-asserted-by":"crossref","unstructured":"Miao J et al (2017) Prostaglandin E 2 and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment. [Online]. Available: www.impactjournals.com\/oncotarget\/","DOI":"10.18632\/oncotarget.21155"},{"issue":"6","key":"4444_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ICB.2011.75","volume":"90","author":"V Sreeramkumar","year":"2011","unstructured":"Sreeramkumar V, Fresno M, Cuesta N (2011) Prostaglandin E2 and T cells: Friends or foes? Immunol Cell Biol 90(6):579. https:\/\/doi.org\/10.1038\/ICB.2011.75","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"4444_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/NM.3831","volume":"21","author":"JH Chen","year":"2015","unstructured":"Chen JH et al (2015) Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection. Nat Med 21(4):327\u2013334. https:\/\/doi.org\/10.1038\/NM.3831","journal-title":"Nat Med"},{"key":"4444_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6616391","volume":"2021","author":"L Tang","year":"2021","unstructured":"Tang L, Zhang Y, Hu Y, Mei H (2021) T cell exhaustion and CAR-T immunotherapy in hematological malignancies. BioMed Res Int 2021:6616391. https:\/\/doi.org\/10.1155\/2021\/6616391","journal-title":"BioMed Res Int"},{"issue":"19","key":"4444_CR29","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1182\/BLOOD.2020007445","volume":"137","author":"MD Jain","year":"2021","unstructured":"Jain MD et al (2021) Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma. Blood 137(19):2621. https:\/\/doi.org\/10.1182\/BLOOD.2020007445","journal-title":"Blood"},{"key":"4444_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0814-7","author":"J Ma","year":"2019","unstructured":"Ma J et al (2019) PD1 Hi CD8 + T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma. J Immunother Cancer. https:\/\/doi.org\/10.1186\/s40425-019-0814-7","journal-title":"J Immunother Cancer"},{"key":"4444_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2023.1192838","volume":"14","author":"C Liu","year":"2023","unstructured":"Liu C, Raab M, Gui Y, Rudd CE (2023) Multi-functional adaptor SKAP1: regulator of integrin activation, the stop-signal, and the proliferation of T cells. Front Immunol 14:1192838. https:\/\/doi.org\/10.3389\/FIMMU.2023.1192838","journal-title":"Front Immunol"},{"issue":"7","key":"4444_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS12071765","volume":"12","author":"D Aldinucci","year":"2020","unstructured":"Aldinucci D, Borghese C, Casagrande N (2020) The CCL5\/CCR5 axis in cancer progression. Cancers Basel 12(7):1765. https:\/\/doi.org\/10.3390\/CANCERS12071765","journal-title":"Cancers Basel"},{"key":"4444_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aap8112","author":"CM Rollings","year":"2018","unstructured":"Rollings CM, Sinclair LV, Brady HJM, Cantrell DA, Ross SH (2018) Interleukin-2 shapes the cytotoxic T cell proteome and immune environment\u2013sensing programs. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.aap8112","journal-title":"Sci Signal"},{"key":"4444_CR34","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross SH, Cantrell DA (2018) Signaling and function of interleukin-2 in T lymphocytes. Annu Rev Immunol 36:411\u2013433. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053352","journal-title":"Annu Rev Immunol"},{"key":"4444_CR35","first-page":"614","volume":"8","author":"Y Rafaeli","year":"1998","unstructured":"Rafaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK (1998) Biochemical mechanisms of IL-2\u2013regulated Fas-mediated T cell apoptosis. Immunity 8:614\u2013623","journal-title":"Immunity"},{"issue":"3","key":"4444_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/S41590-020-00850-9","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor. Nat Immunol 22(3):358\u2013369. https:\/\/doi.org\/10.1038\/S41590-020-00850-9","journal-title":"Nat Immunol"},{"issue":"2","key":"4444_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102584","volume":"7","author":"J Cheng","year":"2026","unstructured":"Cheng J et al (2026) Efficacy and safety of autologous CD5-KO anti-CD5 CAR-T cells in relapsed\/refractory CD5+ hematological malignancies. Cell Rep Med 7(2):102584. https:\/\/doi.org\/10.1016\/j.xcrm.2026.102584","journal-title":"Cell Rep Med"},{"key":"4444_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/JITC-2025-012243","author":"J Wu","year":"2025","unstructured":"Wu J et al (2025) CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicity. J Immunother Cancer. https:\/\/doi.org\/10.1136\/JITC-2025-012243","journal-title":"J Immunother Cancer"},{"issue":"2","key":"4444_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/J.IMMUNI.2013.07.013","volume":"39","author":"MV Kim","year":"2013","unstructured":"Kim MV, Ouyang W, Liao W, Zhang MQ, Li MO (2013) The transcription factor Foxo1 controls central memory CD8+ T cell responses to infection. Immunity 39(2):10.1016\/j.immuni.2013.07.013. https:\/\/doi.org\/10.1016\/J.IMMUNI.2013.07.013","journal-title":"Immunity"},{"key":"4444_CR40","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.981670","author":"M Testoni","year":"2015","unstructured":"Testoni M, Chung EYL, Priebe V, Bertoni F (2015) The transcription factor ETS1 in lymphomas: Friend or foe? Leuk Lymphoma. https:\/\/doi.org\/10.3109\/10428194.2014.981670","journal-title":"Leuk Lymphoma"},{"issue":"1_Supplement","key":"4444_CR41","doi-asserted-by":"publisher","first-page":"98.56","DOI":"10.4049\/JIMMUNOL.206.SUPP.98.56","volume":"206","author":"SM Tsuda","year":"2021","unstructured":"Tsuda SM et al (2021) Ets1 governs the differential formation of circulating and tissue-resident memory CD8 T cells. J Immunol 206(1_Supplement):98.56-98.56. https:\/\/doi.org\/10.4049\/JIMMUNOL.206.SUPP.98.56","journal-title":"J Immunol"},{"issue":"1","key":"4444_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1074-7613(03)00176-6","volume":"19","author":"G Hern\u00e1ndez-Hoyos","year":"2003","unstructured":"Hern\u00e1ndez-Hoyos G, Anderson MK, Wang C, Rothenberg EV, Alberola-Ila J (2003) GATA-3 expression is controlled by TCR signals and regulates CD4\/CD8 differentiation. Immunity 19(1):83\u201394. https:\/\/doi.org\/10.1016\/S1074-7613(03)00176-6","journal-title":"Immunity"},{"issue":"11","key":"4444_CR43","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1172\/JCI57456","volume":"121","author":"EA Wohlfert","year":"2011","unstructured":"Wohlfert EA et al (2011) GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J Clin Invest 121(11):4503\u20134515. https:\/\/doi.org\/10.1172\/JCI57456","journal-title":"J Clin Invest"},{"key":"4444_CR44","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1423183","author":"B Pyrzynska","year":"2018","unstructured":"Pyrzynska B et al (2018) FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. Oncoimmunology. https:\/\/doi.org\/10.1080\/2162402X.2017.1423183","journal-title":"Oncoimmunology"},{"key":"4444_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2024.106518","volume":"168","author":"J Hanna","year":"2024","unstructured":"Hanna J, de la Roche M (2024) Hedgehog signalling in CD4+ T helper cell polarisation. Int J Biochem Cell Biol 168:106518. https:\/\/doi.org\/10.1016\/j.biocel.2024.106518","journal-title":"Int J Biochem Cell Biol"},{"issue":"6163","key":"4444_CR46","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1126\/SCIENCE.1244689","volume":"342","author":"M De La Roche","year":"2013","unstructured":"De La Roche M et al (2013) Hedgehog signaling controls T cell killing at the immunological synapse. Science 342(6163):1247\u20131250. https:\/\/doi.org\/10.1126\/SCIENCE.1244689","journal-title":"Science"},{"issue":"1","key":"4444_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4049\/JIMMUNOL.1701133","volume":"200","author":"SS Majri","year":"2017","unstructured":"Majri SS et al (2017) STAT5B: a differential regulator of the life and death of CD4+ effector memory T cells. J Immunol 200(1):110. https:\/\/doi.org\/10.4049\/JIMMUNOL.1701133","journal-title":"J Immunol"},{"issue":"7","key":"4444_CR48","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.4049\/JIMMUNOL.1002354","volume":"187","author":"A Rani","year":"2011","unstructured":"Rani A et al (2011) IL-2 regulates expression of C-MAF in human CD4 T cells. J Immunol 187(7):3721\u20133729. https:\/\/doi.org\/10.4049\/JIMMUNOL.1002354","journal-title":"J Immunol"},{"issue":"17","key":"4444_CR49","doi-asserted-by":"publisher","first-page":"14963","DOI":"10.1074\/JBC.M111.218867","volume":"286","author":"K Sato","year":"2011","unstructured":"Sato K et al (2011) Marked induction of c-Maf protein during Th17 cell differentiation and its implication in memory Th cell development. J Biol Chem 286(17):14963. https:\/\/doi.org\/10.1074\/JBC.M111.218867","journal-title":"J Biol Chem"},{"issue":"9","key":"4444_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELREP.2025.116177o","volume":"44","author":"A Tripathi","year":"2025","unstructured":"Tripathi A et al (2025) Nrf2 drives activation-driven expansion of CD4+T cells by modulating glucose and glutamine metabolism. Cell Rep 44(9):116177. https:\/\/doi.org\/10.1016\/J.CELREP.2025.116177o","journal-title":"Cell Rep"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04444-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04444-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04444-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:03:01Z","timestamp":1790164981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04444-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4444"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04444-6","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"231"}}